DLA Piper has advised Hungary-based Egis Pharmaceuticals on its acquisition of the D-Panthenol brand, the second largest brand in the dexpanthenol market in Russia, and of a Russian gynaecology portfolio consisting of Vagilac, Feminal and Folacin brands, from Jadran-Galenski Laboratorij. CMS advised the sellers on the deal.
DLA's Moscow-based team was led by Partner Julien Hansen and included Counsel Michael Malloy, Legal Director Pavel Arievich, and Senior Associate Mukhamed Evloev.
The CMS team was led by Bulgarian Managing Partner David Butts and included Veliko Savov and Alexander Rangelov from CMS Sofia, Counsel Vsevolod Tyupa from CMS Moscow, Partner Hrvoje Bardek and Attorney-at-Law Marija Zrno from CMS Zagreb, Patrick Sommer, Daniel Burkhard and Andrea Ferchl from CMS Switzerland, and and John Markham from CMS London.
